|

EMB07 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • EpimAb Biotherapeutics (Suzhou)Co., Ltd.1

Indications

  • Relapse/Refractory Lymphoma1
  • Advanced/Metastatic Solid Tumors1
  • Cancer1

Other1 trial

First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.